Skip to main content
SpringerLink
Log in

Influenza Vaccines for Avian Species

  • Chapter
  • First Online:
Vaccines for Pandemic Influenza

Part of the book series: Current Topics in Microbiology and Immunology ((CT MICROBIOLOGY,volume 333))

Abstract

Beginning in Southeast Asia in 2003, a multinational epizootic outbreak of H5N1 highly pathogenic avian influenza (HPAI) was identified in commercial poultry and wild bird species. This lineage, originally identified in Southern China in 1996 and then Hong Kong in 1997, caused severe morbidity and mortality in many bird species, was responsible for considerable economic losses via trade restrictions, and crossed species barriers (including its recovery from human cases). To date, these H5N1 HPAI viruses have been isolated in European, Middle Eastern, and African countries, and are considered endemic in many areas where regulatory control and different production sectors face substantial hurdles in controlling the spread of this disease. While control of avian influenza (AI) virus infections in wild bird populations may not be feasible at this point, control and eradiation of AI from commercial, semicommercial, zoo, pet, and village/backyard birds will be critical to preventing events that could lead to the emergence of epizootic influenza virus. Efficacious vaccines can help reduce disease, viral shedding, and transmission to susceptible cohorts. However, only when vaccines are used in a comprehensive program including biosecurity, education, culling, diagnostics and surveillance can control and eradication be considered achievable goals. In humans, protection against influenza is provided by vaccines that are chosen based on molecular, epidemiologic, and antigenic data. In poultry and other birds, AI vaccines are produced against a specific hemagglutinin subtype of AI, and use is decided by government and state agricultural authorities based on risk and economic considerations, including the potential for trade restrictions. In the current H5N1 HPAI epizootic, vaccines have been used in a variety of avian species as a part of an overall control program to aid in disease management and control.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Ada GL, Jones PD (1986) The immune response to influenza infection. Curr Top Microbiol Immunol 128:1–54

    CAS  PubMed  Google Scholar 

  • Adriatico N (2005) Controlling AI by vaccination: the Connecticut experience. North Central Avian Disease Conference, pp 25–28

    Google Scholar 

  • Alexander DJ, Parsons G (1980) Protection of chickens against challenge with virulent influenza A viruses of Hav5 subtype conferred by prior infection with influenza A viruses of Hsw1 subtype. Arch Virol 66(3):265–269

    Article  CAS  PubMed  Google Scholar 

  • Allan WH, Madeley CR, Kendal AP (1971) Studies with avian influenza A viruses: cross protection experiments in chickens. J Gen Virol 12(2):79–84

    Article  CAS  PubMed  Google Scholar 

  • Aucouturier J, Dupuis L, Ganne V (2001) Adjuvants designed for veterinary and human vaccines. Vaccine 19(17–19):2666–2672

    Article  CAS  PubMed  Google Scholar 

  • Beard CW (1981) Turkey influenza vaccination. Vet Rec 108(25):545

    CAS  PubMed  Google Scholar 

  • Beard CW, Easterday BC (1973) A-Turkey-Oregon-71, an avirulent influenza isolate with the hemagglutinin of fowl plague virus. Avian Dis 17(1):173–181

    Article  CAS  PubMed  Google Scholar 

  • Beard CW, Schnitzlein WM, Tripathy DN (1992) Effect of route of administration on the efficacy of a recombinant fowlpox virus against H5N2 avian influenza. Avian Dis 36(4):1052–1055

    Article  CAS  PubMed  Google Scholar 

  • Beaudette FR, Hudson CB, Saxe AH (1932) An outbreak of fowl plague in New Jersey in 1929. J Agric Res 49:83–92

    Google Scholar 

  • Beck I, Gerlach H, Burkhardt E, Kaleta EF (2003) Investigation of several selected adjuvants regarding their efficacy and side effects for the production of a vaccine for parakeets to prevent a disease caused by a paramyxovirus type 3. Vaccine 21(9–10):1006–1022

    Article  CAS  PubMed  Google Scholar 

  • Bertelsen MF, Klausen J, Holm E, Grondahl C, Jorgensen PH (2007) Serological response to vaccination against avian influenza in zoo-birds using an inactivated H5N9 vaccine. Vaccine 25(22):4345–4349

    Article  CAS  PubMed  Google Scholar 

  • Boyle DB, Coupar BE (1988) Construction of recombinant fowlpox viruses as vectors for poultry vaccines. Virus Res 10(4):343–356

    Article  CAS  PubMed  Google Scholar 

  • Boyle DB, Selleck P, Heine HG (2000) Vaccinating chickens against avian influenza with fowlpox recombinants expressing the H7 haemagglutinin. Aust Vet J 78(1):44–48

    Article  CAS  PubMed  Google Scholar 

  • Brown DW, Kawaoka Y, Webster RG, Robinson HL (1992) Assessment of retrovirus-expressed nucleoprotein as a vaccine against lethal influenza virus infections of chickens. Avian Dis 36(3):515–520

    Article  CAS  PubMed  Google Scholar 

  • Bublot M, Pritchard N, Swayne DE, Selleck P, Karaca K, Suarez DL, Audonnet JC, Mickle TR (2006) Development and use of fowlpox vectored vaccines for avian influenza. Ann N Y Acad Sci 1081:193–201

    Article  PubMed  Google Scholar 

  • Bublot M, Pritchard N, Cruz JS, Mickle TR, Selleck P, Swayne DE (2007) Efficacy of a fowlpox-vectored avian influenza H5 vaccine against Asian H5N1 highly pathogenic avian influenza virus challenge. Avian Dis 51(suppl 1):498–500

    Article  PubMed  Google Scholar 

  • Capua I, Marangon S (2007a) Control and prevention of avian influenza in an evolving scenario. Vaccine 25(30):5645–5652

    Article  CAS  Google Scholar 

  • Capua I, Marangon S (2007b) The use of vaccination to combat multiple introductions of notifiable avian influenza viruses of the H5 and H7 subtypes between 2000 and 2006 in Italy. Vaccine 25(27):4987–4995

    Article  Google Scholar 

  • Capua I, Terregino C, Cattoli G, Mutinelli F, Rodriguez JF (2003) Development of a DIVA (Differentiating Infected from Vaccinated Animals) strategy using a vaccine containing a heterologous neuraminidase for the control of avian influenza. Avian Pathol 32(1):47–55

    Article  CAS  PubMed  Google Scholar 

  • Capua I, Terregino C, Cattoli G, Toffan A (2004) Increased resistance of vaccinated turkeys to experimental infection with an H7N3 low-pathogenicity avian influenza virus. Avian Pathol 33(2):158–163

    Article  CAS  PubMed  Google Scholar 

  • Cauthen AN, Swayne DE, Sekellick MJ, Marcus PI, Suarez DL (2007) Amelioration of influenza virus pathogenesis in chickens attributed to the enhanced interferon-inducing capacity of a virus with a truncated NS1 gene. J Virol 81(4):1838–1847

    Article  CAS  PubMed  Google Scholar 

  • Chambers TM, Kawaoka Y, Webster RG (1988) Protection of chickens from lethal influenza infection by vaccinia-expressed hemagglutinin. Virology 167(2):414–421

    CAS  PubMed  Google Scholar 

  • Crawford J, Wilkinson B, Vosnesensky A, Smith G, Garcia M, Stone H, Perdue ML (1999) Baculovirus-derived hemagglutinin vaccines protect against lethal influenza infections by avian H5 and H7 subtypes. Vaccine 17(18):2265–2274

    Article  CAS  PubMed  Google Scholar 

  • Cristalli A, Capua I (2007) Practical problems in controlling H5N1 high pathogenicity avian influenza at village level in Vietnam and introduction of biosecurity measures. Avian Dis 51(suppl 1):461–462

    Article  PubMed  Google Scholar 

  • De BK, Shaw MW, Rota PA, Harmon MW, Esposito JJ, Rott R, Cox NJ, Kendal AP (1988) Protection against virulent H5 avian influenza virus infection in chickens by an inactivated vaccine produced with recombinant vaccinia virus. Vaccine 6(3):257–261

    Article  CAS  PubMed  Google Scholar 

  • De Filette M, Min Jou W, Birkett A, Lyons K, Schultz B, Tonkyro A, Resch S, Fiers W (2005) Universal influenza A vaccine: optimization of M2-based constructs. Virology 337(1):149–161

    Article  CAS  PubMed  Google Scholar 

  • De Filette M, Ramne A, Birkett A, Lycke N, Lowenadler B, Min Jou W, Saelens X, and Fiers W (2006) The universal influenza vaccine M2e-HBc administered intranasally in combination with the adjuvant CTA1-DD provides complete protection. Vaccine 24(5):544–551

    CAS  PubMed  Google Scholar 

  • Fatunmbi OO, Newman JA, Sivanandan V, Halvorson DA (1992) Enhancement of antibody response of turkeys to trivalent avian influenza vaccine by positively charged liposomal avridine adjuvant. Vaccine 10(9):623–626

    Article  CAS  PubMed  Google Scholar 

  • Flynn KJ, Belz GT, Altman JD, Ahmed R, Woodland DL, Doherty PC (1998) Virus-specific CD8+ T cells in primary and secondary influenza pneumonia. Immunity 8(6):683–691

    Article  CAS  PubMed  Google Scholar 

  • Folitse R, Halvorson DA, Sivanandan V (1998) Efficacy of combined killed-in-oil emulsion and live Newcastle disease vaccines in chickens. Avian Dis 42(1):173–178

    Article  CAS  PubMed  Google Scholar 

  • Fouchier RA, Munster V, Wallensten A, Bestebroer TM, Herfst S, Smith D, Rimmelzwaan GF, Olsen B, Osterhaus AD (2005) Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls. J Virol 79(5):2814–2822

    Article  CAS  PubMed  Google Scholar 

  • Fynan EF, Robinson HL, Webster RG (1993) Use of DNA encoding influenza hemagglutinin as an avian influenza vaccine. DNA Cell Biol 12(9):785–789

    Article  CAS  PubMed  Google Scholar 

  • Gao W, Soloff AC, Lu X, Montecalvo A, Nguyen DC, Matsuoka Y, Robbins PD, Swayne DE, Donis RO, Katz JM, Barratt-Boyes SM, Gambotto A (2006) Protection of mice and poultry from lethal H5N1 avian influenza virus through adenovirus-based immunization. J Virol 80(4):1959–1964

    Article  CAS  PubMed  Google Scholar 

  • Ge J, Deng G, Wen Z, Tian G, Wang Y, Shi J, Wang X, Li Y, Hu S, Jiang Y, Yang C, Yu K, Bu Z, Chen H (2007) Newcastle disease virus-based live attenuated vaccine completely protects chickens and mice from lethal challenge of homologous and heterologous H5N1 avian influenza viruses. J Virol 81(1):150–158

    Article  CAS  PubMed  Google Scholar 

  • Halvorson DA, Kelleher CJ, Senne DA (1985) Epizootiology of avian influenza: effect of season on incidence in sentinel ducks and domestic turkeys in Minnesota. Appl Environ Microbiol 49(4):914–919

    CAS  PubMed  Google Scholar 

  • He Q, Mitchell A, Morcol T, Bell SJ (2002) Calcium phosphate nanoparticles induce mucosal immunity and protection against herpes simplex virus type 2. Clin Diagn Lab Immunol 9(5):1021–1024

    CAS  PubMed  Google Scholar 

  • Hu KF, Lovgren-Bengtsson K, Morein B (2001) Immunostimulating complexes (ISCOMs) for nasal vaccination. Adv Drug Deliv Rev 51(1–3):149–159

    Article  CAS  PubMed  Google Scholar 

  • Huleatt JW, Nakaar V, Desai P, Huang Y, Hewitt D, Jacobs A, Tang J, McDonald W, Song L, Evans RK, Umlauf S, Tussey L, Powell TJ (2008) Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin. Vaccine 26(2):201–214

    Article  CAS  PubMed  Google Scholar 

  • Hulse-Post DJ, Sturm-Ramirez KM, Humberd J, Seiler P, Govorkova EA, Krauss S, Scholtissek C, Puthavathana P, Buranathai C, Nguyen TD, Long HT, Naipospos TS, Chen H, Ellis TM, Guan Y, Peiris JS, Webster RG (2005) Role of domestic ducks in the propagation and biological evolution of highly pathogenic H5N1 influenza viruses in Asia. Proc Natl Acad Sci USA 102(30):10682–10687

    Article  CAS  PubMed  Google Scholar 

  • Hunt LA, Brown DW, Robinson HL, Naeve CW, Webster RG (1988) Retrovirus-expressed hemagglutinin protects against lethal influenza virus infections. J Virol 62(8):3014–3019

    CAS  PubMed  Google Scholar 

  • Jansen T, Hofmans MP, Theelen MJ, Manders F, Schijns VE (2006) Structure- and oil type-based efficacy of emulsion adjuvants. Vaccine 24(26):5400–5405

    Article  CAS  PubMed  Google Scholar 

  • Jia L, Peng D, Zhang Y, Liu H, Liu X (2003) Construction, genetic stability and protective efficacy of recombinant fowlpox virus expressing hemagglutinin gene of H5N1 subtype avian influenza virus. Wei Sheng Wu Xue Bao 43(6):722–727

    CAS  PubMed  Google Scholar 

  • Katz D, Inbar I, Samina I, Peleg BA, Heller DE (1993) Comparison of dimethyl dioctadecyl ammonium bromide, Freund’s complete adjuvant and mineral oil for induction of humoral antibodies, cellular immunity and resistance to Newcastle disease virus in chickens. FEMS Immunol Med Microbiol 7(4):303–313

    Article  CAS  PubMed  Google Scholar 

  • King DJ (1991) Evaluation of different methods of inactivation of Newcastle disease virus and avian influenza virus in egg fluids and serum. Avian Dis 35(3):505–514

    Article  CAS  PubMed  Google Scholar 

  • Lambkin R, Dimmock NJ (1996) Longitudinal study of an epitope-biased serum haemagglutination-inhibition antibody response in rabbits immunized with type A influenza virions. Vaccine 14(3):212–218

    Article  CAS  PubMed  Google Scholar 

  • Lawrence CW, Ream RM, Braciale TJ (2005) Frequency, specificity, and sites of expansion of CD8+ T cells during primary pulmonary influenza virus infection. J Immunol 174(9):5332–5340

    CAS  PubMed  Google Scholar 

  • Le Gall-Recule G, Cherbonnel M, Pelotte N, Blanchard P, Morin Y, Jestin V (2007) Importance of a prime-boost DNA/protein vaccination to protect chickens against low-pathogenic H7 avian influenza infection. Avian Dis 51(suppl 1):490–494

    Article  CAS  PubMed  Google Scholar 

  • Lee CW, Suarez DL (2005) Avian influenza virus: prospects for prevention and control by vaccination. Anim Health Res Rev 6(1):1–15

    Article  PubMed  Google Scholar 

  • Luschow D, Werner O, Mettenleiter TC, Fuchs W (2001) Protection of chickens from lethal avian influenza A virus infection by live-virus vaccination with infectious laryngotracheitis virus recombinants expressing the hemagglutinin (H5) gene. Vaccine 19(30):4249–4259

    Article  CAS  PubMed  Google Scholar 

  • Marangon S, Cecchinato M, Capua I (2008) Use of vaccination in avian influenza control and eradication. Zoonoses Public Health 55(1):65–72

    CAS  PubMed  Google Scholar 

  • Martinet W, Saelens X, Deroo T, Neirynck S, Contreras R, Min Jou W, Fiers W (1997) Protection of mice against a lethal influenza challenge by immunization with yeast-derived recombinant influenza neuraminidase. Eur J Biochem 247(1):332–338

    Article  CAS  PubMed  Google Scholar 

  • McCapes RH, Bankowski RA (1987) Use of avian influenza vaccines in California turkey breeders. In: Proceedings of the Second International Symposium on Avian Influenza. US Animal Health Association, Richmond, VA, pp 271–278

    Google Scholar 

  • McNulty MS, Allan GM, Adair BM (1986) Efficacy of avian influenza neuraminidase-specific vaccines in chickens. Avian Pathology 15:107–115

    Article  CAS  PubMed  Google Scholar 

  • Middleton D, Bingham J, Selleck P, Lowther S, Gleeson L, Lehrbach P, Robinson S, Rodenberg J, Kumar M, Andrew M (2007) Efficacy of inactivated vaccines against H5N1 avian influenza infection in ducks. Virology 359(1):66–71

    Article  PubMed  Google Scholar 

  • Oh S, Martelli P, Hock OS, Luz S, Furley C, Chiek EJ, Wee LC, Keun NM (2005) Field study on the use of inactivated H5N2 vaccine in avian species. Vet Rec 157(10):299–300

    PubMed  Google Scholar 

  • Park MS, Steel J, Garcia-Sastre A, Swayne D, Palese P (2006) Engineered viral vaccine constructs with dual specificity: avian influenza and Newcastle disease. Proc Natl Acad Sci USA 103(21):8203–8208

    Article  CAS  PubMed  Google Scholar 

  • Philippa JD, Munster VJ, Bolhuis H, Bestebroer TM, Schaftenaar W, Beyer WE, Fouchier RA, Kuiken T, Osterhaus AD (2005) Highly pathogenic avian influenza (H7N7): vaccination of zoo birds and transmission to non-poultry species. Vaccine 23(50):5743–5750

    Article  CAS  PubMed  Google Scholar 

  • Philippa J, Baas C, Beyer W, Bestebroer T, Fouchier R, Smith D, Schaftenaar W, Osterhaus A (2007) Vaccination against highly pathogenic avian influenza H5N1 virus in zoos using an adjuvanted inactivated H5N2 vaccine. Vaccine 25(19):3800–3808

    CAS  PubMed  Google Scholar 

  • Price RJ (1981) Commercial avian influenza vaccines. In: Proceedings of the First International Symposium on Avian Influenza. US Animal Health Association, Richmond, VA, pp 178–179

    Google Scholar 

  • Qiao CL, Yu KZ, Jiang YP, Jia YQ, Tian GB, Liu M, Deng GH, Wang XR, Meng QW, Tang XY (2003) Protection of chickens against highly lethal H5N1 and H7N1 avian influenza viruses with a recombinant fowlpox virus co-expressing H5 haemagglutinin and N1 neuraminidase genes. Avian Pathol 32(1):25–32

    Article  CAS  PubMed  Google Scholar 

  • Qiao C, Yu K, Jiang Y, Li C, Tian G, Wang X, Chen H (2006) Development of a recombinant fowlpox virus vector-based vaccine of H5N1 subtype avian influenza. Dev Biol (Basel) 124:127–132

    CAS  Google Scholar 

  • Robinson HL, Hunt LA, Webster RG (1993) Protection against a lethal influenza virus challenge by immunization with a haemagglutinin-expressing plasmid DNA. Vaccine 11(9):957–960

    Article  CAS  PubMed  Google Scholar 

  • Roth JA (1999) Mechanistic bases for adverse vaccine reactions and vaccine failures. Adv Vet Med 41:681–700

    Article  CAS  PubMed  Google Scholar 

  • Rott R, Becht H, Orlich M (1974) The significance of influenza virus neuraminidase in immunity. J Gen Virol 22(1):35–41

    Article  CAS  PubMed  Google Scholar 

  • Saelens X, Vanlandschoot P, Martinet W, Maras M, Neirynck S, Contreras R, Fiers W, Jou WM (1999) Protection of mice against a lethal influenza virus challenge after immunization with yeast-derived secreted influenza virus hemagglutinin. Eur J Biochem 260(1):166–175

    Article  CAS  PubMed  Google Scholar 

  • Sambhara S, Kurichh A, Miranda R, Tumpey T, Rowe T, Renshaw M, Arpino R, Tamane A, Kandil A, James O, Underdown B, Klein M, Katz J, Burt D (2001) Heterosubtypic immunity against human influenza A viruses, including recently emerged avian H5 and H9 viruses, induced by FLU-ISCOM vaccine in mice requires both cytotoxic T-lymphocyte and macrophage function. Cell Immunol 211(2):143–153

    Article  CAS  PubMed  Google Scholar 

  • Schijns VE (2003) Mechanisms of vaccine adjuvant activity: initiation and regulation of immune responses by vaccine adjuvants. Vaccine 21(9–10):829–831

    Article  PubMed  Google Scholar 

  • Schijns VE, Tangeras A (2005) Vaccine adjuvant technology: from theoretical mechanisms to practical approaches. Dev Biol (Basel) 121:127–134

    CAS  Google Scholar 

  • Schultz-Cherry S, Dybing JK, Davis NL, Williamson C, Suarez DL, Johnston R, Perdue ML (2000) Influenza virus (A/HK/156/97) hemagglutinin expressed by an alphavirus replicon system protects chickens against lethal infection with Hong Kong-origin H5N1 viruses. Virology 278(1):55–59

    Article  CAS  PubMed  Google Scholar 

  • Seo SH, Webster RG (2001) Cross-reactive, cell-mediated immunity and protection of chickens from lethal H5N1 influenza virus infection in Hong Kong poultry markets. J Virol 75(6):2516–2525

    Article  CAS  PubMed  Google Scholar 

  • Sims LD (2007) Lessons learned from Asian H5N1 outbreak control. Avian Dis 51(suppl 1):174–181

    Article  CAS  PubMed  Google Scholar 

  • Steensels M, Van Borm S, Lambrecht B, De Vriese J, Le Gros FX, Bublot M, van den Berg T (2007) Efficacy of an inactivated and a fowlpox-vectored vaccine in Muscovy ducks against an Asian H5N1 highly pathogenic avian influenza viral challenge. Avian Dis 51(suppl 1):325–331

    Article  CAS  PubMed  Google Scholar 

  • Stephenson I, Bugarini R, Nicholson KG, Podda A, Wood JM, Zambon MC, Katz JM (2005) Cross-reactivity to highly pathogenic avian influenza H5N1 viruses after vaccination with nonadjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a potential priming strategy. J Infect Dis 191(8):1210–1215

    Article  PubMed  Google Scholar 

  • Stone HD (1986) Efficacy of avian influenza oil-emulsion vaccines in chickens of various ages. Avian Dis 31:483–490

    Article  Google Scholar 

  • Stone HD (1989) Efficacy of oil-emulsion vaccines prepared with pigeon paramyxovirus-1, Ulster, and La Sota Newcastle Disease virus. Avian Dis 33:157–162

    Article  CAS  PubMed  Google Scholar 

  • Stone HD (1993) Efficacy of experimental animal and vegetable oil-emulsion vaccines for Newcastle disease and avian influenza. Avian Dis 37(2):399–405

    Article  CAS  PubMed  Google Scholar 

  • Stone HD (1997) Newcastle disease oil emulsion vaccines prepared with animal, vegetable, and synthetic oils. Avian Dis 41(3):591–597

    Article  CAS  PubMed  Google Scholar 

  • Suarez DL, Schultz-Cherry S (2000) The effect of eukaryotic expression vectors and adjuvants on DNA vaccines in chickens using an avian influenza model. Avian Dis 44(4):861–868

    Article  CAS  PubMed  Google Scholar 

  • Suarez DL, Lee CW, Swayne DE (2006) Avian influenza vaccination in North America: strategies and difficulties. Dev Biol (Basel) 124:117–124

    CAS  Google Scholar 

  • Swayne DE (2003) Vaccines for List A poultry diseases: emphasis on avian influenza. Dev Biol (Basel) 114:201–212

    CAS  Google Scholar 

  • Swayne DE (2006) Principles for vaccine protection in chickens and domestic waterfowl against avian influenza: emphasis on Asian H5N1 high pathogenicity avian influenza. Ann N Y Acad Sci 1081:174–181

    Article  PubMed  Google Scholar 

  • Swayne DE, Halvorson DA (2003) Influenza. In: Saif YM, Barnes HJ, Fadly AM, Glisson JR (eds) Diseases of poultry, 11th edn. Iowa State University Press, Ames, IA, pp 135–160

    Google Scholar 

  • Swayne DE, Halvorson DA (2008) Influenza. In: Saif YM, Barnes HJ, Fadly A, Glisson JR, McDougald LR, Nolan L, Swayne DE (eds) Diseases of poultry, vol 12. Iowa State University Press, Ames, IA (in press)

    Google Scholar 

  • Swayne DE, Kapczynski DR (2008) Vaccines, vaccination, and immunology for avian influenza viruses in poultry. In: Swayne DE (ed) Avian influenza. Blackwell, Ames, IA, pp 407–451

    Chapter  Google Scholar 

  • Swayne DE, Beck JR, Mickle TR (1997) Efficacy of recombinant fowl poxvirus vaccine in protecting chickens against a highly pathogenic Mexican-origin H5N2 avian influenza virus. Avian Dis 41(4):910–922

    Article  CAS  PubMed  Google Scholar 

  • Swayne DE, Beck JR, Marcia M, Stone HD (1999) Influence of virus strain and antigen mass on efficacy of H5 avian influenza inactivated vaccines. Avian Pathology 28:245–255

    Article  Google Scholar 

  • Swayne DE, Garcia M, Beck JR, Kinney N, Suarez DL (2000) Protection against diverse highly pathogenic H5 avian influenza viruses in chickens immunized with a recombinant fowlpox vaccine containing an H5 avian influenza hemagglutinin gene insert. Vaccine 18(11–12):1088–1095

    Article  CAS  PubMed  Google Scholar 

  • Swayne DE, Suarez DL, Schultz-Cherry S, Tumpey TM, King DJ, Nakaya T, Palese P, Garcia-Sastre A (2003) Recombinant paramyxovirus type 1-avian influenza-H7 virus as a vaccine for protection of chickens against influenza and Newcastle disease. Avian Dis 47(suppl 3):1047–1050

    Article  CAS  PubMed  Google Scholar 

  • Sylte MJ, Hubby B, Suarez DL (2007) Influenza neuraminidase antibodies provide partial protection for chickens against high pathogenic avian influenza infection. Vaccine 25(19):3763–3772

    Article  CAS  PubMed  Google Scholar 

  • Todd C (1928) Experiments on the virus of fowl plague. Br J Exp Pathol 9:101–106

    Google Scholar 

  • Toro H, Tang DC, Suarez DL, Sylte MJ, Pfeiffer J, Van Kampen KR (2007) Protective avian influenza in ovo vaccination with non-replicating human adenovirus vector. Vaccine 25(15):2886–2891

    Article  CAS  PubMed  Google Scholar 

  • Tumpey TM, Kapazynsk DR, Swayne DE (2004) Comparative susceptibility of chickens and turkeys to avian influenza A H7N2 vins infection and protective efficacy of a commercial avian influenza H7N2 vins vaccine. Avian Dis 48(1):167–176.

    Article  PubMed  Google Scholar 

  • van der Goot JA, Koch G, de Jong MC, van Boven M (2005) Quantification of the effect of vaccination on transmission of avian influenza (H7N7) in chickens. Proc Natl Acad Sci USA 102(50):18141–18146

    Article  CAS  PubMed  Google Scholar 

  • van der Goot JA, van Boven M, Koch G, de Jong MC (2007) Variable effect of vaccination against highly pathogenic avian influenza (H7N7) virus on disease and transmission in pheasants and teals. Vaccine 25(49):8318–8325

    Article  CAS  PubMed  Google Scholar 

  • Veits J, Luschow D, Kindermann K, Werner O, Teifke JP, Mettenleiter TC, Fuchs W (2003) Deletion of the non-essential UL0 gene of infectious laryngotracheitis (ILT) virus leads to attenuation in chickens, and UL0 mutants expressing influenza virus haemagglutinin (H7) protect against ILT and fowl plague. J Gen Virol 84(Pt 12):3343–3352

    Article  CAS  PubMed  Google Scholar 

  • Veits J, Wiesner D, Fuchs W, Hoffmann B, Granzow H, Starick E, Mundt E, Schirrmeier H, Mebatsion T, Mettenleiter TC, Romer-Oberdorfer A (2006) Newcastle disease virus expressing H5 hemagglutinin gene protects chickens against Newcastle disease and avian influenza. Proc Natl Acad Sci USA 103(21):8197–8202

    Article  CAS  PubMed  Google Scholar 

  • Villareal CL (2006) Control and eradication strategies of avian influneza in Mexico. Dev Biol 124:125–126

    Google Scholar 

  • Vogel FR (2000) Improving vaccine performance with adjuvants. Clin Infect Dis 30(suppl 3):S266–S270

    Article  CAS  PubMed  Google Scholar 

  • Watanabe T, Watanabe S, Kim JH, Hatta M, Kawaoka Y (2008) Novel approach to the development of effective H5N1 influenza A virus vaccines: use of M2 cytoplasmic tail mutants. J Virol 82(5):2486–2492

    Article  CAS  PubMed  Google Scholar 

  • Webster RG, Kawaoka Y, Taylor J, Weinberg R, Paoletti E (1991) Efficacy of nucleoprotein and haemagglutinin antigens expressed in fowlpox virus as vaccine for influenza in chickens. Vaccine 9(5):303–308

    Article  CAS  PubMed  Google Scholar 

  • Xie ZX, Stone HD (1990) Immune response to oil-emulsion vaccines with single or mixed antigens of Newcastle disease, avian influenza, and infectious bronchitis. Avian Dis 34(1):154–162

    Article  CAS  PubMed  Google Scholar 

  • Zanella A, Poli G, Bigami M (1981) Avian influenza: approaches in the control of disease with inactivated vaccines in oil emulsion. In: Proceedings of the First International Symposium on Avian Influenza. US Animal Health Association, Richmond, VA, pp 180–183

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Exotic and Emerging Avian Viral Diseases Research Unit, Southeast Poultry Research Laboratory, USDA–Agricultural Research Service–South Atlantic Area, 934 College Station Road, Athens, GA, 30605, USA

    Darrell R. Kapczynski & David E. Swayne

Authors
  1. Darrell R. Kapczynski
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David E. Swayne
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Darrell R. Kapczynski .

Editor information

Editors and Affiliations

  1. School of Medicine, Emory University, Atlanta, 30322, U.S.A.

    Richard W. Compans

  2. School of Medicine, Emory University, Clifton Road 1510, Atlanta, 30322, U.S.A.

    Walter A. Orenstein

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Kapczynski, D.R., Swayne, D.E. (2009). Influenza Vaccines for Avian Species. In: Compans, R., Orenstein, W. (eds) Vaccines for Pandemic Influenza. Current Topics in Microbiology and Immunology, vol 333. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-92165-3_6

Download citation

Publish with us

Policies and ethics

Search

Navigation